Search results for "ASIS"

showing 10 items of 4190 documents

The Homeostasis of Brain Choline

1993

The interest in the homeostasis of brain choline is reinforced by the role of choline as immediate precursor of acetylcholine, phosphatidylcholine and other phospholipids in the brain. In order to obtain a comprehensive view of the mochanisms of homeostasis it appeared necessary to elucidate the negative arteriovenous difference of choline across the brain (net release), a phenomenon that has been known for 20 years and is present in mammals and in man. This finding prompted an intense search for a de novo synthesis of choline in the brain. We detected in anaesthetized rats a reversal of the net release into a net uptake (positive arterio-venous difference), when the plasma level of choline…

medicine.medical_specialtyChemistryDe novo synthesischemistry.chemical_compoundEndocrinologyPhosphatidylcholineInternal medicinemedicineExtracellularPhosphorylationCholineAcetylcholineHomeostasismedicine.drugPhosphocholine
researchProduct

Glucose Metabolism in Children With Growth Hormone Deficiency

2018

Background: The growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis has a fundamental impact on glucose metabolism. Therefore, both untreated GH deficiency (GHD) and GH treatment (GHT) may be associated with some metabolic alterations, although the abnormalities of glucose metabolism have been investigated by relatively few studies as main outcomes. Aim: The present review summarizes the available data on glucose metabolism in children with GHD, providing an overview of the current state of the art in order better to clarify the real metabolic impact of GHD and GHT. Methods: Among all the existing studies, we evaluated all original studies that fulfilled our criteria for analysis …

medicine.medical_specialtyChildren; Glucose; Growth hormone; Insulin sensitivity; Metabolism; Endocrinology Diabetes and MetabolismEndocrinology Diabetes and MetabolismMini Review030209 endocrinology & metabolismCarbohydrate metabolismGrowth hormonelcsh:Diseases of the endocrine glands. Clinical endocrinologyReporting parametersGrowth hormone deficiencySettore MED/13 - EndocrinologiaFasting glucose03 medical and health sciences0302 clinical medicineInsulin resistanceEndocrinologychildrenInternal medicinemedicineGlucose homeostasisinsulin sensitivityglucoselcsh:RC648-665business.industryMetabolismmedicine.diseaseEndocrinology030220 oncology & carcinogenesisgrowth hormonebusinessmetabolismFrontiers in Endocrinology
researchProduct

Primary Biliary Cholangitis: advances in management and treatment of the disease

2017

Primary Biliary Cholangitis, previously known as Primary Biliary Cirrhosis, is a rare disease, which mainly affects women in their fifth to seventh decades of life. It is a chronic autoimmune disease characterized by a progressive damage of interlobular bile ducts leading to ductopenia, chronic cholestasis and bile acids retention. Even if the disease usually presents a long asymptomatic phase and a slow progression, in many patients it may progress faster toward cirrhosis and its complications. The 10Â year mortality is greater than in diseases such as human immunodeficiency virus/Hepatitis C Virus coinfection and breast cancer. Ursodeoxycholic acid is the only treatment available today, b…

medicine.medical_specialtyCholagogues and CholereticsCirrhosisPrimary Biliary CholangitisCholangitisDiseaseChenodeoxycholic AcidGastroenterologyEnd Stage Liver Disease03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePrimary biliary cirrhosisDuctopeniaAlkaline phosphatase; Budesonide; Fibrates; Obeticholic acid; Ursodeoxycholic acid; Hepatology; GastroenterologyMED/12 - GASTROENTEROLOGIAInternal medicineAlkaline phosphatasemedicineHumansFibrateSettore SECS-P/01 - Economia PoliticaBudesonideCholestasisHepatologyAlkaline phosphatase; Budesonide; Fibrates; Obeticholic acid; Ursodeoxycholic acidbusiness.industryGastroenterologyObeticholic acidHepatologymedicine.diseaseUrsodeoxycholic acidchemistryUrsodeoxycholic acid030220 oncology & carcinogenesisObeticholic acidDisease Progression030211 gastroenterology & hepatologyDrug Therapy CombinationbusinessFibratesbiologicalRare diseasemedicine.drug
researchProduct

DISOPYRAMIDE-INDUCED INTRAHEPATIC CHOLESTASIS

1977

medicine.medical_specialtyCholestasisbusiness.industryInternal medicineMedicineGeneral Medicinebusinessmedicine.diseaseDisopyramideGastroenterologymedicine.drugThe Lancet
researchProduct

Primary ciliary dyskinesia assessment by means of optical flow analysis of phase-contrast microscopy images

2014

Primary ciliary dyskinesia implies cilia with defective or total absence of motility, which may result in sinusitis, chronic bronchitis, bronchiectasis and male infertility. Diagnosis can be difficult and is based on an abnormal ciliary beat frequency (CBF) and beat pattern. In this paper, we present a method to determine CBF of isolated cells through the analysis of phase-contrast microscopy images, estimating cilia motion by means of an optical flow algorithm. After having analyzed 28 image sequences (14 with a normal beat pattern and 14 with a dyskinetic pattern), the normal group presented a CBF of 5.2 +/- 1.6 Hz, while the dyskinetic patients presented a 1.9 +/- 0.9 Hz CBF. The cutoff …

medicine.medical_specialtyChronic bronchitisPhase contrast microscopyOptical flowBeat (acoustics)Health InformaticsSensitivity and SpecificityPattern Recognition Automatedlaw.inventionTECNOLOGIA ELECTRONICAPrimary ciliary dyskinesialawOphthalmologyImage Interpretation Computer-AssistedMicroscopymedicineHumansMicroscopy Phase-ContrastRadiology Nuclear Medicine and imagingPrimary ciliary dyskinesiaMicroscopy VideoBronchiectasisRadiological and Ultrasound Technologybusiness.industryCiliumOptical flowActive contoursReproducibility of ResultsAnatomyImage Enhancementmedicine.diseaseComputer Graphics and Computer-Aided DesignCell TrackingSubtraction TechniqueFISICA APLICADABeat frequencyComputer Vision and Pattern RecognitionbusinessMATEMATICA APLICADAAlgorithmsFourier-Mellin transformCiliary Motility Disorders
researchProduct

Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis

2000

Aim: To establish the efficacy of combination therapy with ursodeoxycholic acid (UDCA) and colchicine in patients with symptomatic primary biliary cirrhosis (PBC), defined by the presence of liver cirrhosis, pruritus or bilirubin exceeding 2 mg/mL. Methods: A total of 90 patients were randomly assigned to ursodeoxycholic acid 500 mg/daily plus placebo (UDCA group, n=44), or ursodeoxycholic acid at the same dosage plus colchicine, 1 mg/daily (UDCA/C group, n=46). The two groups were comparable for age, sex, stage of disease, severity of pruritus, bilirubin, and Mayo score. All patients underwent clinical, ultrasonographic, and biochemical examinations at entry and then every 6 months up to 3…

medicine.medical_specialtyCirrhosisHepatologymedicine.diagnostic_testbusiness.industryBiliary cirrhosisGastroenterologyPlacebo-controlled studymedicine.diseasePlaceboGastroenterologyUrsodeoxycholic acidPrimary biliary cirrhosisCholestasisLiver biopsyInternal medicinemedicinePharmacology (medical)businessmedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

The Clinical Course of Portal Hypertension in Liver Cirrhosis

2000

Portal hypertension is caused by liver cirrhosis in almost %% of patients in Europe and in North America. Other causes such as hepato-splenic schistosomiasis, noncirrhotic portal fibrosis and extrahepatic portal vein thrombosis are more common in Asia and South America.

medicine.medical_specialtyCirrhosisbusiness.industryPortal venous pressurePortal hypertensive gastropathySchistosomiasismedicine.diseaseGastroenterologyPortal vein thrombosisEsophageal varicesInternal medicinePortal fibrosismedicinePortal hypertensionbusiness
researchProduct

A Cholestatic Pattern Predicts Liver-Related Events in Patients with Nonalcoholic Fatty Liver Disease

2021

Background & Aims: Liver test alteration patterns can be categorized as: predominantly hepatocellular(H), with an ALT/ALP ratio>5; predominantly cholestatic pattern(C) with a ratio 55 years(HR2.55,95%C.I.1.17-5.54;p=0.01), platelets<150,000/mmc(HR0.14,95%C.I.0.06-0.32;p<0.001), albumin<4g/L(HR0.62,95%C.I.0.35-1.08;p=0.09), C vs M pattern(HR7.86,95%C.I.1.03-60.1;p=0.04), C vs H pattern(HR12.1,95% C.I.1.61-90.9;p=0.01) and fibrosis F3-F4(HR35.8,95%C.I.4.65-275.2;p<0.001) were independent risk factors for LRE occurrence. C vs M pattern(HR14.3,95%C.I.1.90-105.6;p=0.008) and C vs H pattern(HR15.6,95%C.I. 2.10-115.1;p=0.0068) were confirmed independently associated with LRE occurrence in the vali…

medicine.medical_specialtyCirrhosisbusiness.industryProportional hazards modelmedicine.diseaseGastroenterologyLiver diseaseCholestasisMetaplasiaInternal medicineCohortNonalcoholic fatty liver diseaseMedicineIn patientmedicine.symptombusinessSSRN Electronic Journal
researchProduct

Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective s…

2020

Aim HCV infection increases the risk of type 2 diabetes mellitus (T2DM). However, it remains still unclear whether HCV clearance by direct-acting antivirals (DAA) reduces T2DM. Therefore, the effect of HCV eradication on T2DM incidence was assessed. Methods A prospective multicenter case-control study was performed, which included 2,426 HCV patients, 42% of which with liver fibrosis F0-F2 and 58% F3-F4. Study population consisted of a control group including 1099 untreated patients and 1327 cases treated with DAA. T2DM incidence was assessed during a follow-up median period of 30 [IQR: 28-42] months. Risk factors of T2DM were assessed by Cox regression model (Relative risk (RR), Hazard risk…

medicine.medical_specialtyCirrhosisendocrine system diseasesEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematologyAntiviral AgentsGastroenterology03 medical and health sciences0302 clinical medicineEndocrinologychronic hepatitiInternal medicineInternal MedicinemedicineHumansGlucose homeostasisProspective StudiesProspective cohort studydirect-acting antiviralbusiness.industryIncidenceIncidence (epidemiology)nutritional and metabolic diseasesType 2 Diabetes MellitusHepatitis C Chronicmedicine.diseaseDiabetes Mellitus Type 2Case-Control StudiesRelative riskHCVPopulation studytype 2 diabetesbusinesscirrhositype 2 diabetes.
researchProduct

Pulmonary metastasectomy in colorectal cancer: a prospective study of demography and clinical characteristics of 543 patients in the Spanish colorect…

2013

Objectives To capture an accurate contemporary description of the practice of pulmonary metastasectomy for colorectal carcinoma in one national healthcare system. Design A national registry set up in Spain by Grupo Espanol de Cirugia Metastasis Pulmonares de Carcinoma Colo-Rectal (GECMP-CCR). Setting 32 Spanish thoracic units. Participants All patients with one or more histologically proven lung metastasis removed by surgery between March 2008 and February 2010. Interventions Pulmonary metastasectomy for one or more pulmonary nodules proven to be metastatic colorectal carcinoma. Primary and secondary outcome measures The age and sex of the patients having this surgery were recorded with the…

medicine.medical_specialtyCirurgia colorectalMediastinal lymphadenopathyColorectal cancerMetastasisMetastasisCarcinoembryonic antigenMetàstasiCàncer colorectalColorectal surgerymedicineCarcinoma1506Prospective cohort studyPathological16941695biologybusiness.industryResearchGeneral surgeryGeneral Medicinemedicine.diseaseColorectal cancerSurgeryOncologybiology.protein1737Metastasectomy1717business
researchProduct